The most recent treatments and drugs for treating and transplanting the liver will be discussed at this conference. We’ll go over the outcomes of clinical studies and actual patient data on oral medications used to treat chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma, and end-stage liver disease complications like thrombocytopenia. A thorough yet succinct curriculum called New Treatments in Chronic Liver Disease keeps doctors up to date on issues like these and others that come up frequently when treating liver illnesses.
Education-Related Goals
Participants should be able to: • Evaluate AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease after taking part in this live activity.
• Go through the fundamentals of managing coagulation in individuals with chronic liver disease.
• Provide a summary of the recommendations for NAFLD (AGA), DILI, hemochromatosis (ACG), and non-invasive fibrosis indicators (EASL).
• Assess the effectiveness of PBC and PSC drug candidates.
• Use methods for managing and treating hepatorenal syndrome and ascites.
• Outline developments in HCC therapy and acute-on-chronic liver disease care.
Target Audience: Specialists in infectious diseases, gastroenterologists, and hepatologists
Topics:
ACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD
Acute-on-Chronic Liver Disease – Timothy Morgan, MD
Advanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD
Advances in HCC – Catherine Frenette, MD
AGA Guidelines for NAFLD – Mazen Noureddin, MD
Autoimmune Hepatitis – John Vierling, MD
Debate- Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD
EASL Guidelines for Non-Invasive Testing – Michael Charlton, MD
Panel Discussion1
Panel Discussion2
Panel Discussion3
Reproductive Health and Chronic Liver Disease – Norah Terrault, MD
Update on Management of Ascites and HRS – Florence Wong, MD
Vascular Disorders and Anticoagulation – Patrick Northup, MD
Viral Hepatitis B and C – Julio Gutierrez, MD
When to Refer for Liver Transplantation – Adam Deising, MD
WILLIAM S. HAUBRICH LECTURE- What’s New in PBC and PSC- – Kris Kowdley, MD
